ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Human Chorionic Gonadotropin (HCG) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-28Z6789
Home | Market Reports | Health| Reproductive Health
Global Human Chorionic Gonadotropin HCG Market Insights and Forecast to 2028
BUY CHAPTERS

Human Chorionic Gonadotropin (HCG) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-28Z6789
Report
September 2024
Pages:124
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
EMD Serono Inc
Ferring B.V.
Merck& Co. Inc
Bristol Myers Squibb Company
Leebio
Kamiya Biomedical Company
Sanzyme
Cigna
Fresenius Kabi AG
Scripps Laboratories
Lupin Ltd
Sun Pharmaceutical Industries Ltd.
Serum Institute of India Pvt. Ltd
Zydus Lifesciences Ltd
Corona Remedies Pvt Ltd
VHB Medi Sciences Limited

Human Chorionic Gonadotropin (HCG) - Market Size

The global market for Human Chorionic Gonadotropin (HCG) was estimated to be worth US$ 745.2 million in 2023 and is forecast to a readjusted size of US$ 1173.2 million by 2030 with a CAGR of 6.6% during the forecast period 2024-2030

Human Chorionic Gonadotropin (HCG) - Market

Human Chorionic Gonadotropin (HCG) - Market

Human chorionic gonadotropin (HCG) is a female hormone produced by the placenta after implantation of the egg, which is why it can be detected in a few pregnancy tests. In addition, it can be extracted from the urine of pregnant women or produced from cultures of genetically modified cells using recombinant DNA technology.
The growth of the human chorionic gonadotropin (HCG) market is attributed to the increasing prevalence of infertility and hypogonadism, changing lifestyles, and increased awareness regarding infertility treatment. Hypogonadism, for example, is characterized by low serum testosterone concentration, which is followed by a number of clinical features such as erectile dysfunction (ED), poor morning erections, low libido, memory loss, physical decline in strength and health, difficulty concentrating, and depression.According to the study published by BMC Endocrine Disorders in July 2021, erectile dysfunction was found to be prevalent in 72.2% of people globally in 2021. Furthermore, according to the CDC update in March 2022, about 1 in 5 (22%) couples in which the woman is 30-39 have problems conceiving their first child, compared to about 1 in 8 (13%) couples in which the woman is younger than 30. Age-related fertility loss is mostly caused by deteriorating egg quality. Older women also have fewer remaining eggs and are more likely to have health issues that can affect fertility. Aging also increases a woman’s chances of miscarriage and of having a child with a genetic abnormality. Therefore, the high burden of infertility is also raising the demand for effective treatments such as human chorionic gonadotropin (HCG) hormones, which is fueling the market's growth.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Chorionic Gonadotropin (HCG), focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Human Chorionic Gonadotropin (HCG) by region & country, by Type, and by Application.
The Human Chorionic Gonadotropin (HCG) market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Chorionic Gonadotropin (HCG).
Market Segmentation

Scope of Human Chorionic Gonadotropin (HCG) - Market Report

Report Metric Details
Report Name Human Chorionic Gonadotropin (HCG) - Market
Forecasted market size in 2030 US$ 1173.2 million
CAGR 6.6%
Forecasted years 2024 - 2030
Segment by Type:
  • Natural Source Extraction
  • Recombinant DNA Technology
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company EMD Serono, Inc, Ferring B.V, Merck & Co., Inc, Bristol Myers Squibb Company, Fresenius Kabi AG, Scripps Laboratories, Leebio, Kamiya Biomedical Company, Sanzyme, Cigna, LUPIN, Sun Pharmaceutical Industries Ltd, Serum Institute of India Pvt. Ltd, VHB Medi Sciences Limited, Zydus Lifesciences Ltd, Corona Remedies Pvt. Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Human Chorionic Gonadotropin (HCG) manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Human Chorionic Gonadotropin (HCG) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Human Chorionic Gonadotropin (HCG) in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Human Chorionic Gonadotropin (HCG) - Market size in 2030?

Ans: The Human Chorionic Gonadotropin (HCG) - Market size in 2030 will be US$ 1173.2 million.

Who are the main players in the Human Chorionic Gonadotropin (HCG) - Market report?

Ans: The main players in the Human Chorionic Gonadotropin (HCG) - Market are EMD Serono, Inc, Ferring B.V, Merck & Co., Inc, Bristol Myers Squibb Company, Fresenius Kabi AG, Scripps Laboratories, Leebio, Kamiya Biomedical Company, Sanzyme, Cigna, LUPIN, Sun Pharmaceutical Industries Ltd, Serum Institute of India Pvt. Ltd, VHB Medi Sciences Limited, Zydus Lifesciences Ltd, Corona Remedies Pvt. Ltd.

What are the Application segmentation covered in the Human Chorionic Gonadotropin (HCG) - Market report?

Ans: The Applications covered in the Human Chorionic Gonadotropin (HCG) - Market report are Female Infertility Treatment, Oligospermic Treatment, Cryptorchidism Treatment, Others

What are the Type segmentation covered in the Human Chorionic Gonadotropin (HCG) - Market report?

Ans: The Types covered in the Human Chorionic Gonadotropin (HCG) - Market report are Natural Source Extraction, Recombinant DNA Technology

Recommended Reports

Pregnancy & Fertility

Reproductive Hormones

Women's Health Drugs

1 Market Overview
1.1 Human Chorionic Gonadotropin (HCG) Product Introduction
1.2 Global Human Chorionic Gonadotropin (HCG) Market Size Forecast
1.3 Human Chorionic Gonadotropin (HCG) Market Trends & Drivers
1.3.1 Human Chorionic Gonadotropin (HCG) Industry Trends
1.3.2 Human Chorionic Gonadotropin (HCG) Market Drivers & Opportunity
1.3.3 Human Chorionic Gonadotropin (HCG) Market Challenges
1.3.4 Human Chorionic Gonadotropin (HCG) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Human Chorionic Gonadotropin (HCG) Players Revenue Ranking (2023)
2.2 Global Human Chorionic Gonadotropin (HCG) Revenue by Company (2019-2024)
2.3 Key Companies Human Chorionic Gonadotropin (HCG) Manufacturing Base Distribution and Headquarters
2.4 Key Companies Human Chorionic Gonadotropin (HCG) Product Offered
2.5 Key Companies Time to Begin Mass Production of Human Chorionic Gonadotropin (HCG)
2.6 Human Chorionic Gonadotropin (HCG) Market Competitive Analysis
2.6.1 Human Chorionic Gonadotropin (HCG) Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Human Chorionic Gonadotropin (HCG) Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Chorionic Gonadotropin (HCG) as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Natural Source Extraction
3.1.2 Recombinant DNA Technology
3.2 Global Human Chorionic Gonadotropin (HCG) Sales Value by Type
3.2.1 Global Human Chorionic Gonadotropin (HCG) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Human Chorionic Gonadotropin (HCG) Sales Value, by Type (2019-2030)
3.2.3 Global Human Chorionic Gonadotropin (HCG) Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Female Infertility Treatment
4.1.2 Oligospermic Treatment
4.1.3 Cryptorchidism Treatment
4.1.4 Others
4.2 Global Human Chorionic Gonadotropin (HCG) Sales Value by Application
4.2.1 Global Human Chorionic Gonadotropin (HCG) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Human Chorionic Gonadotropin (HCG) Sales Value, by Application (2019-2030)
4.2.3 Global Human Chorionic Gonadotropin (HCG) Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Human Chorionic Gonadotropin (HCG) Sales Value by Region
5.1.1 Global Human Chorionic Gonadotropin (HCG) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Human Chorionic Gonadotropin (HCG) Sales Value by Region (2019-2024)
5.1.3 Global Human Chorionic Gonadotropin (HCG) Sales Value by Region (2025-2030)
5.1.4 Global Human Chorionic Gonadotropin (HCG) Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Human Chorionic Gonadotropin (HCG) Sales Value, 2019-2030
5.2.2 North America Human Chorionic Gonadotropin (HCG) Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Human Chorionic Gonadotropin (HCG) Sales Value, 2019-2030
5.3.2 Europe Human Chorionic Gonadotropin (HCG) Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Human Chorionic Gonadotropin (HCG) Sales Value, 2019-2030
5.4.2 Asia Pacific Human Chorionic Gonadotropin (HCG) Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Human Chorionic Gonadotropin (HCG) Sales Value, 2019-2030
5.5.2 South America Human Chorionic Gonadotropin (HCG) Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales Value, 2019-2030
5.6.2 Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Human Chorionic Gonadotropin (HCG) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Human Chorionic Gonadotropin (HCG) Sales Value
6.3 United States
6.3.1 United States Human Chorionic Gonadotropin (HCG) Sales Value, 2019-2030
6.3.2 United States Human Chorionic Gonadotropin (HCG) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Human Chorionic Gonadotropin (HCG) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Human Chorionic Gonadotropin (HCG) Sales Value, 2019-2030
6.4.2 Europe Human Chorionic Gonadotropin (HCG) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Human Chorionic Gonadotropin (HCG) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Human Chorionic Gonadotropin (HCG) Sales Value, 2019-2030
6.5.2 China Human Chorionic Gonadotropin (HCG) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Human Chorionic Gonadotropin (HCG) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Human Chorionic Gonadotropin (HCG) Sales Value, 2019-2030
6.6.2 Japan Human Chorionic Gonadotropin (HCG) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Human Chorionic Gonadotropin (HCG) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Human Chorionic Gonadotropin (HCG) Sales Value, 2019-2030
6.7.2 South Korea Human Chorionic Gonadotropin (HCG) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Human Chorionic Gonadotropin (HCG) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Human Chorionic Gonadotropin (HCG) Sales Value, 2019-2030
6.8.2 Southeast Asia Human Chorionic Gonadotropin (HCG) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Human Chorionic Gonadotropin (HCG) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Human Chorionic Gonadotropin (HCG) Sales Value, 2019-2030
6.9.2 India Human Chorionic Gonadotropin (HCG) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Human Chorionic Gonadotropin (HCG) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 EMD Serono, Inc
7.1.1 EMD Serono, Inc Profile
7.1.2 EMD Serono, Inc Main Business
7.1.3 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Products, Services and Solutions
7.1.4 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) & (2019-2024)
7.1.5 EMD Serono, Inc Recent Developments
7.2 Ferring B.V
7.2.1 Ferring B.V Profile
7.2.2 Ferring B.V Main Business
7.2.3 Ferring B.V Human Chorionic Gonadotropin (HCG) Products, Services and Solutions
7.2.4 Ferring B.V Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) & (2019-2024)
7.2.5 Ferring B.V Recent Developments
7.3 Merck & Co., Inc
7.3.1 Merck & Co., Inc Profile
7.3.2 Merck & Co., Inc Main Business
7.3.3 Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Products, Services and Solutions
7.3.4 Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) & (2019-2024)
7.3.5 Bristol Myers Squibb Company Recent Developments
7.4 Bristol Myers Squibb Company
7.4.1 Bristol Myers Squibb Company Profile
7.4.2 Bristol Myers Squibb Company Main Business
7.4.3 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Products, Services and Solutions
7.4.4 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) & (2019-2024)
7.4.5 Bristol Myers Squibb Company Recent Developments
7.5 Fresenius Kabi AG
7.5.1 Fresenius Kabi AG Profile
7.5.2 Fresenius Kabi AG Main Business
7.5.3 Fresenius Kabi AG Human Chorionic Gonadotropin (HCG) Products, Services and Solutions
7.5.4 Fresenius Kabi AG Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) & (2019-2024)
7.5.5 Fresenius Kabi AG Recent Developments
7.6 Scripps Laboratories
7.6.1 Scripps Laboratories Profile
7.6.2 Scripps Laboratories Main Business
7.6.3 Scripps Laboratories Human Chorionic Gonadotropin (HCG) Products, Services and Solutions
7.6.4 Scripps Laboratories Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) & (2019-2024)
7.6.5 Scripps Laboratories Recent Developments
7.7 Leebio
7.7.1 Leebio Profile
7.7.2 Leebio Main Business
7.7.3 Leebio Human Chorionic Gonadotropin (HCG) Products, Services and Solutions
7.7.4 Leebio Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) & (2019-2024)
7.7.5 Leebio Recent Developments
7.8 Kamiya Biomedical Company
7.8.1 Kamiya Biomedical Company Profile
7.8.2 Kamiya Biomedical Company Main Business
7.8.3 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Products, Services and Solutions
7.8.4 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) & (2019-2024)
7.8.5 Kamiya Biomedical Company Recent Developments
7.9 Sanzyme
7.9.1 Sanzyme Profile
7.9.2 Sanzyme Main Business
7.9.3 Sanzyme Human Chorionic Gonadotropin (HCG) Products, Services and Solutions
7.9.4 Sanzyme Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) & (2019-2024)
7.9.5 Sanzyme Recent Developments
7.10 Cigna
7.10.1 Cigna Profile
7.10.2 Cigna Main Business
7.10.3 Cigna Human Chorionic Gonadotropin (HCG) Products, Services and Solutions
7.10.4 Cigna Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) & (2019-2024)
7.10.5 Cigna Recent Developments
7.11 LUPIN
7.11.1 LUPIN Profile
7.11.2 LUPIN Main Business
7.11.3 LUPIN Human Chorionic Gonadotropin (HCG) Products, Services and Solutions
7.11.4 LUPIN Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) & (2019-2024)
7.11.5 LUPIN Recent Developments
7.12 Sun Pharmaceutical Industries Ltd
7.12.1 Sun Pharmaceutical Industries Ltd Profile
7.12.2 Sun Pharmaceutical Industries Ltd Main Business
7.12.3 Sun Pharmaceutical Industries Ltd Human Chorionic Gonadotropin (HCG) Products, Services and Solutions
7.12.4 Sun Pharmaceutical Industries Ltd Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) & (2019-2024)
7.12.5 Sun Pharmaceutical Industries Ltd Recent Developments
7.13 Serum Institute of India Pvt. Ltd
7.13.1 Serum Institute of India Pvt. Ltd Profile
7.13.2 Serum Institute of India Pvt. Ltd Main Business
7.13.3 Serum Institute of India Pvt. Ltd Human Chorionic Gonadotropin (HCG) Products, Services and Solutions
7.13.4 Serum Institute of India Pvt. Ltd Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) & (2019-2024)
7.13.5 Serum Institute of India Pvt. Ltd Recent Developments
7.14 VHB Medi Sciences Limited
7.14.1 VHB Medi Sciences Limited Profile
7.14.2 VHB Medi Sciences Limited Main Business
7.14.3 VHB Medi Sciences Limited Human Chorionic Gonadotropin (HCG) Products, Services and Solutions
7.14.4 VHB Medi Sciences Limited Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) & (2019-2024)
7.14.5 VHB Medi Sciences Limited Recent Developments
7.15 Zydus Lifesciences Ltd
7.15.1 Zydus Lifesciences Ltd Profile
7.15.2 Zydus Lifesciences Ltd Main Business
7.15.3 Zydus Lifesciences Ltd Human Chorionic Gonadotropin (HCG) Products, Services and Solutions
7.15.4 Zydus Lifesciences Ltd Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) & (2019-2024)
7.15.5 Zydus Lifesciences Ltd Recent Developments
7.16 Corona Remedies Pvt. Ltd.
7.16.1 Corona Remedies Pvt. Ltd. Profile
7.16.2 Corona Remedies Pvt. Ltd. Main Business
7.16.3 Corona Remedies Pvt. Ltd. Human Chorionic Gonadotropin (HCG) Products, Services and Solutions
7.16.4 Corona Remedies Pvt. Ltd. Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) & (2019-2024)
7.16.5 Corona Remedies Pvt. Ltd. Recent Developments
8 Industry Chain Analysis
8.1 Human Chorionic Gonadotropin (HCG) Industrial Chain
8.2 Human Chorionic Gonadotropin (HCG) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Human Chorionic Gonadotropin (HCG) Sales Model
8.5.2 Sales Channel
8.5.3 Human Chorionic Gonadotropin (HCG) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
FEATURED COMPANIES
EMD Serono Inc
Ferring B.V.
Merck& Co. Inc
Bristol Myers Squibb Company
Leebio
Kamiya Biomedical Company
Sanzyme
Cigna
Fresenius Kabi AG
Scripps Laboratories
Lupin Ltd
Sun Pharmaceutical Industries Ltd.
Serum Institute of India Pvt. Ltd
Zydus Lifesciences Ltd
Corona Remedies Pvt Ltd
VHB Medi Sciences Limited
List of Tables
    Table 1. Human Chorionic Gonadotropin (HCG) Market Trends
    Table 2. Human Chorionic Gonadotropin (HCG) Market Drivers & Opportunity
    Table 3. Human Chorionic Gonadotropin (HCG) Market Challenges
    Table 4. Human Chorionic Gonadotropin (HCG) Market Restraints
    Table 5. Global Human Chorionic Gonadotropin (HCG) Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Human Chorionic Gonadotropin (HCG) Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Human Chorionic Gonadotropin (HCG) Product Type
    Table 9. Key Companies Time to Begin Mass Production of Human Chorionic Gonadotropin (HCG)
    Table 10. Global Human Chorionic Gonadotropin (HCG) Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Chorionic Gonadotropin (HCG) as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Human Chorionic Gonadotropin (HCG) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Human Chorionic Gonadotropin (HCG) Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Human Chorionic Gonadotropin (HCG) Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Human Chorionic Gonadotropin (HCG) Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Human Chorionic Gonadotropin (HCG) Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Human Chorionic Gonadotropin (HCG) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Human Chorionic Gonadotropin (HCG) Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Human Chorionic Gonadotropin (HCG) Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Human Chorionic Gonadotropin (HCG) Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Human Chorionic Gonadotropin (HCG) Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Human Chorionic Gonadotropin (HCG) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Human Chorionic Gonadotropin (HCG) Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Human Chorionic Gonadotropin (HCG) Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Human Chorionic Gonadotropin (HCG) Sales Value by Region (2019-2024) & (%)
    Table 27. Global Human Chorionic Gonadotropin (HCG) Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Human Chorionic Gonadotropin (HCG) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Human Chorionic Gonadotropin (HCG) Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Human Chorionic Gonadotropin (HCG) Sales Value, (2025-2030) & (US$ Million)
    Table 31. EMD Serono, Inc Basic Information List
    Table 32. EMD Serono, Inc Description and Business Overview
    Table 33. EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Human Chorionic Gonadotropin (HCG) Business of EMD Serono, Inc (2019-2024)
    Table 35. EMD Serono, Inc Recent Developments
    Table 36. Ferring B.V Basic Information List
    Table 37. Ferring B.V Description and Business Overview
    Table 38. Ferring B.V Human Chorionic Gonadotropin (HCG) Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Human Chorionic Gonadotropin (HCG) Business of Ferring B.V (2019-2024)
    Table 40. Ferring B.V Recent Developments
    Table 41. Merck & Co., Inc Basic Information List
    Table 42. Merck & Co., Inc Description and Business Overview
    Table 43. Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Human Chorionic Gonadotropin (HCG) Business of Merck & Co., Inc (2019-2024)
    Table 45. Merck & Co., Inc Recent Developments
    Table 46. Bristol Myers Squibb Company Basic Information List
    Table 47. Bristol Myers Squibb Company Description and Business Overview
    Table 48. Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Human Chorionic Gonadotropin (HCG) Business of Bristol Myers Squibb Company (2019-2024)
    Table 50. Bristol Myers Squibb Company Recent Developments
    Table 51. Fresenius Kabi AG Basic Information List
    Table 52. Fresenius Kabi AG Description and Business Overview
    Table 53. Fresenius Kabi AG Human Chorionic Gonadotropin (HCG) Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Human Chorionic Gonadotropin (HCG) Business of Fresenius Kabi AG (2019-2024)
    Table 55. Fresenius Kabi AG Recent Developments
    Table 56. Scripps Laboratories Basic Information List
    Table 57. Scripps Laboratories Description and Business Overview
    Table 58. Scripps Laboratories Human Chorionic Gonadotropin (HCG) Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Human Chorionic Gonadotropin (HCG) Business of Scripps Laboratories (2019-2024)
    Table 60. Scripps Laboratories Recent Developments
    Table 61. Leebio Basic Information List
    Table 62. Leebio Description and Business Overview
    Table 63. Leebio Human Chorionic Gonadotropin (HCG) Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Human Chorionic Gonadotropin (HCG) Business of Leebio (2019-2024)
    Table 65. Leebio Recent Developments
    Table 66. Kamiya Biomedical Company Basic Information List
    Table 67. Kamiya Biomedical Company Description and Business Overview
    Table 68. Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Human Chorionic Gonadotropin (HCG) Business of Kamiya Biomedical Company (2019-2024)
    Table 70. Kamiya Biomedical Company Recent Developments
    Table 71. Sanzyme Basic Information List
    Table 72. Sanzyme Description and Business Overview
    Table 73. Sanzyme Human Chorionic Gonadotropin (HCG) Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Human Chorionic Gonadotropin (HCG) Business of Sanzyme (2019-2024)
    Table 75. Sanzyme Recent Developments
    Table 76. Cigna Basic Information List
    Table 77. Cigna Description and Business Overview
    Table 78. Cigna Human Chorionic Gonadotropin (HCG) Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Human Chorionic Gonadotropin (HCG) Business of Cigna (2019-2024)
    Table 80. Cigna Recent Developments
    Table 81. LUPIN Basic Information List
    Table 82. LUPIN Description and Business Overview
    Table 83. LUPIN Human Chorionic Gonadotropin (HCG) Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Human Chorionic Gonadotropin (HCG) Business of LUPIN (2019-2024)
    Table 85. LUPIN Recent Developments
    Table 86. Sun Pharmaceutical Industries Ltd Basic Information List
    Table 87. Sun Pharmaceutical Industries Ltd Description and Business Overview
    Table 88. Sun Pharmaceutical Industries Ltd Human Chorionic Gonadotropin (HCG) Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Human Chorionic Gonadotropin (HCG) Business of Sun Pharmaceutical Industries Ltd (2019-2024)
    Table 90. Sun Pharmaceutical Industries Ltd Recent Developments
    Table 91. Serum Institute of India Pvt. Ltd Basic Information List
    Table 92. Serum Institute of India Pvt. Ltd Description and Business Overview
    Table 93. Serum Institute of India Pvt. Ltd Human Chorionic Gonadotropin (HCG) Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Human Chorionic Gonadotropin (HCG) Business of Serum Institute of India Pvt. Ltd (2019-2024)
    Table 95. Serum Institute of India Pvt. Ltd Recent Developments
    Table 96. VHB Medi Sciences Limited Basic Information List
    Table 97. VHB Medi Sciences Limited Description and Business Overview
    Table 98. VHB Medi Sciences Limited Human Chorionic Gonadotropin (HCG) Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Human Chorionic Gonadotropin (HCG) Business of VHB Medi Sciences Limited (2019-2024)
    Table 100. VHB Medi Sciences Limited Recent Developments
    Table 101. Zydus Lifesciences Ltd Basic Information List
    Table 102. Zydus Lifesciences Ltd Description and Business Overview
    Table 103. Zydus Lifesciences Ltd Human Chorionic Gonadotropin (HCG) Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Human Chorionic Gonadotropin (HCG) Business of Zydus Lifesciences Ltd (2019-2024)
    Table 105. Zydus Lifesciences Ltd Recent Developments
    Table 106. Corona Remedies Pvt. Ltd. Basic Information List
    Table 107. Corona Remedies Pvt. Ltd. Description and Business Overview
    Table 108. Corona Remedies Pvt. Ltd. Human Chorionic Gonadotropin (HCG) Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Human Chorionic Gonadotropin (HCG) Business of Corona Remedies Pvt. Ltd. (2019-2024)
    Table 110. Corona Remedies Pvt. Ltd. Recent Developments
    Table 111. Key Raw Materials Lists
    Table 112. Raw Materials Key Suppliers Lists
    Table 113. Human Chorionic Gonadotropin (HCG) Downstream Customers
    Table 114. Human Chorionic Gonadotropin (HCG) Distributors List
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
    Table 118. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Human Chorionic Gonadotropin (HCG) Product Picture
    Figure 2. Global Human Chorionic Gonadotropin (HCG) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Human Chorionic Gonadotropin (HCG) Sales Value (2019-2030) & (US$ Million)
    Figure 4. Human Chorionic Gonadotropin (HCG) Report Years Considered
    Figure 5. Global Human Chorionic Gonadotropin (HCG) Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Chorionic Gonadotropin (HCG) Revenue in 2023
    Figure 7. Human Chorionic Gonadotropin (HCG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Natural Source Extraction Picture
    Figure 9. Recombinant DNA Technology Picture
    Figure 10. Global Human Chorionic Gonadotropin (HCG) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Human Chorionic Gonadotropin (HCG) Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Female Infertility Treatment
    Figure 13. Product Picture of Oligospermic Treatment
    Figure 14. Product Picture of Cryptorchidism Treatment
    Figure 15. Product Picture of Others
    Figure 16. Global Human Chorionic Gonadotropin (HCG) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Human Chorionic Gonadotropin (HCG) Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Human Chorionic Gonadotropin (HCG) Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Human Chorionic Gonadotropin (HCG) Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Human Chorionic Gonadotropin (HCG) Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Human Chorionic Gonadotropin (HCG) Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Human Chorionic Gonadotropin (HCG) Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Human Chorionic Gonadotropin (HCG) Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Human Chorionic Gonadotropin (HCG) Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Human Chorionic Gonadotropin (HCG) Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Human Chorionic Gonadotropin (HCG) Sales Value (%), (2019-2030)
    Figure 29. United States Human Chorionic Gonadotropin (HCG) Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Human Chorionic Gonadotropin (HCG) Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Human Chorionic Gonadotropin (HCG) Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Human Chorionic Gonadotropin (HCG) Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Human Chorionic Gonadotropin (HCG) Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Human Chorionic Gonadotropin (HCG) Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Human Chorionic Gonadotropin (HCG) Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Human Chorionic Gonadotropin (HCG) Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Human Chorionic Gonadotropin (HCG) Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Human Chorionic Gonadotropin (HCG) Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Human Chorionic Gonadotropin (HCG) Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Human Chorionic Gonadotropin (HCG) Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Human Chorionic Gonadotropin (HCG) Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Human Chorionic Gonadotropin (HCG) Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Human Chorionic Gonadotropin (HCG) Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Human Chorionic Gonadotropin (HCG) Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Human Chorionic Gonadotropin (HCG) Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Human Chorionic Gonadotropin (HCG) Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Human Chorionic Gonadotropin (HCG) Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Human Chorionic Gonadotropin (HCG) Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Human Chorionic Gonadotropin (HCG) Sales Value by Application (%), 2023 VS 2030
    Figure 50. Human Chorionic Gonadotropin (HCG) Industrial Chain
    Figure 51. Human Chorionic Gonadotropin (HCG) Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Human Chorionic Gonadotropin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chorionic Gonadotrophin Market Research Report 2024
Global Pregnancy Test Stick Market Research Report 2025
Global Human Chorionic Gonadotropin Test Kit Market Research Report 2024
Global HCG Rapid Test Market Research Report 2024
Global HCG Blood Test Pregnancy Test Market Research Report 2025
Global HCG Urine Test Pregnancy Test Market Research Report 2025
Global Human Chorionic Gonadotrophin HCG Market Research Report 2025
Global Quantitative hCG Pregnancy Test Market Research Report 2024
Global Pregnancy Test Sticks and Strips Market Research Report 2025
Global Pregnancy Detection Kits Market Research Report 2024
Global Urine Pregnancy Test Kit Market Research Report 2025
Global Menotropin Market Research Report 2024
Global hCG Pregnancy Test Strip Market Research Report 2025
Global Beta Human Chorionic Gonadotropin HCG ELISA Test Kit Market Research Report 2024
Global Pregnancy and Fertility Testing Kits Market Insights Forecast to 2030
Global Home Pregnancy Tests Market Research Report 2025
Global At Home Pregnancy Testing Market Research Report 2025
Recombinant Human Chorionic Gonadotropin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Human Somatropin for Injection Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions